Future Pain Drugs - Europe 2003. 15-16 September 2003, London, UK.
Xerion Pharmaceuticals AG, D-82152 Martinsried, Germany. l.ilag@xerion-pharma.com
Vic L
VL
Ilag
D000082:Acetaminophen / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use; D000085:Acetates / Q000737:chemistry / Q000627:therapeutic use; D000588:Amines; D000700:Analgesics / Q000737:chemistry / Q000627:therapeutic use; D000818:Animals; D003509:Cyclohexanecarboxylic Acids; D004195:Disease Models, Animal; D016503:Drug Delivery Systems; D005632:Fructose / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D000077287:Levetiracetam; D009566:Nitrates / Q000737:chemistry / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D010889:Piracetam / Q000031:analogs & derivatives / Q000737:chemistry / Q000627:therapeutic use; D000069583:Pregabalin; D000077236:Topiramate; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use
D000085:Acetates; D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D009566:Nitrates; D000077236:Topiramate; D005632:Fructose; D000082:Acetaminophen; D000077287:Levetiracetam; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; C478738:4-(nitroxy)butanoic acid 4-acetylaminophenyl ester; D010889:Piracetam